It’s high time science bid farewell to the default male model in animal research, according to the neurologist Rebecca Shansky.   Since 2016 sex has been a required variable in NIH studies, but the bias persists, she writes in a commentary in Science.  

Women account for over half of people living with HIV worldwide. That’s not obvious from the research, which relies heavily on gay male participants. Yet there are key differences in how male and female immune systems respond to the virus—a relevant factor in efforts to…

Armed with tempting sums of cash, Juul Labs has been aggressively recruiting e-cigarette researchers in a bid to show the FDA—by 2022—that its blockbuster vape products are a “net public health good” when it comes to promoting smoking cessation, Sheila Kaplan reports.…

The first clinical trial of deep brain stimulation for drug addiction launched in Shanghai and may be heading to the US. In the past, DBS—surgical implantation of a device in the brain that can electronically stimulate specific areas—has yielded mixed results. A recent…

Before the US FDA greenlit the world’s first dengue vaccine last week, Dengvaxia made headlines for a deployment in the Philippines that led to criminal charges. After its 2016 rollout, concerns emerged that the embattled vaccine given to 100,000 Philippine children could…

The US is poised to set a measles record this year with dozens of new cases cropping up in recent weeks and more expected in the wake of Easter and Passover gatherings, The Washington Post reports. The cases, mostly among unvaccinated populations, are linked to travelers…

Ketchup has gone through a lot to get where it is today. Beyond tomatoes, it’s “a thick mixture of politics, personality, a 20th-century acceptance that food safety matters”—starting with Henry Heinz in the 20th century, writes Deborah Blum. Early ketchup products were ripe…

As the US government shutdown stretches into week 3, food safety, hurricane preparedness and scientific infrastructure are working well below capacity—compromising American's safety. From the FDA to the Federal Aviation Administration, 800,000 federal employees are…

While they come with risks, unapproved treatments can be a game-changer for patients who’ve exhausted other options. But there’s a striking racial disparity among participants in drug trials. Black patients made up less than 5% of participants in trials for 24 of the 31…

For the last 4 years, a generic blood pressure drug containing a potentially carcinogenic substance—an inadvertent chemical byproduct—has been circulating the market.